BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 26811150)

  • 1. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
    Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
    Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
    Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.
    Zorzi M; Hassan C; Capodaglio G; Narne E; Turrin A; Baracco M; Dal Cin A; Fiore A; Martin G; Repici A; Rex D; Rugge M
    Ann Intern Med; 2018 Nov; 169(9):602-609. PubMed ID: 30285055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test.
    Crotta S; Segnan N; Paganin S; Dagnes B; Rosset R; Senore C
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):633-8. PubMed ID: 22426085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attendance and yield over three rounds of population-based fecal immunochemical test screening.
    Kapidzic A; Grobbee EJ; Hol L; van Roon AH; van Vuuren AJ; Spijker W; Izelaar K; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2014 Aug; 109(8):1257-64. PubMed ID: 24980879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Stegeman I; van Doorn SC; Mundt MW; Mallant-Hent RC; Bongers E; Elferink MA; Fockens P; Stroobants AK; Bossuyt PM; Dekker E
    Cancer Epidemiol; 2015 Jun; 39(3):388-93. PubMed ID: 25910865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.
    Selby K; Jensen CD; Lee JK; Doubeni CA; Schottinger JE; Zhao WK; Chubak J; Halm E; Ghai NR; Contreras R; Skinner C; Kamineni A; Levin TR; Corley DA
    Ann Intern Med; 2018 Oct; 169(7):439-447. PubMed ID: 30242328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
    Alsayid M; Singh MH; Issaka R; Laleau V; Day L; Lee J; Allison J; Somsouk M
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1593-1597.e1. PubMed ID: 29660528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
    Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
    [No Abstract]   [Full Text] [Related]  

  • 17. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
    Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.
    Stegeman I; de Wijkerslooth TR; Mallant-Hent RC; de Groot K; Stroobants AK; Fockens P; Mundt M; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2012 Jun; 12():73. PubMed ID: 22713100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer.
    Baldacchini F; Bucchi L; Giuliani O; Mancini S; Ravaioli A; Vattiato R; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Mezzetti F; Sassoli de Bianchi P; Ferretti S; Falcini F;
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2361-2369. PubMed ID: 32827723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.